Tech Company Financing Transactions
Ivantis Funding Round
Ivantis, operating out of Irvine, raised $17 million in funding from Delphi Ventures and New Enterprise Associates.
Transaction Overview
Company Name
Announced On
6/27/2011
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Series B
Investors
Delphi Ventures (Douglas Roeder)
New Enterprise Associates (John Nehra)
Proceeds Purpose
The funds will be used to expand clinical activities for the Hydrus, the world's first intracanalicular ("in the canal") scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 60 million people worldwide. These funds, which constitute the second round of financing, will be used to support multiple randomized controlled trials around the world, including in the United States.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
201 Technology
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
Ivantis, Inc. is a company dedicated to the development of new and innovative solutions for glaucoma. Current therapies for primary open angle glaucoma (POAG) include eye drops, laser therapy, and surgery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dave Meter
Chief Scientific Officer
Brett Trauthen
VP - Marketing
Michael Chodzko
VP - Operations
Todd Abraham
VP - R & D
Ken Galt
VP - Regulatory Affairs
Helene Spencer
VP - Sales
Frank Shields
Browse more venture capital transactions:
Prev: 6/27/2011: Moda Operandi venture capital transaction
Next: 6/28/2011: Viralheat venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs